Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS +50.00%·Rev n/aQ1 21EPS +19.35%·Rev n/aQ4 20EPS -5.66%·Rev n/aQ3 20EPS +19.05%·Rev n/a⚠ consensus missing

HALOZYME THERAPEUTICS, INC. HALO

Tram Bui — Vice President of Corporate Communications and Investor Relations

Bob Apple — Chief Executive Officer

Joe Renda — Executive, likely President or Chief Commercial Officer

Peter Richardson — Executive, likely Chief Scientific Officer or Head of R&D

Fred Powell — Chief Financial Officer

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HALO calls or request research access.

More HALO calls Browse calls Request research access